Article Abstract

Cost-effectiveness of model-based eligibility for lung cancer screening in the routine clinical practice

Authors: Salvatore Intagliata, Elisa Roca, Deborah Cosentini, Alfredo Berruti


In the 2018 the American Cancer Society estimates about 234,030 new cases of lung cancer (121,680 in men and 112,350 in women) and about 154,050 deaths from lung cancer (83,550 in men and 70,500 in women) in the US (1).